Bruker (BRKR) Tops Q2 EPS by 2c, Maintains Guidance

Bruker (NASDAQ: BRKR) reported Q2 EPS of $0.19, $0.02 better than the analyst estimate of $0.17. Revenue for the quarter came in at $396 million versus the consensus estimate of $392.06 million.

2015 Financial Outlook

Bruker’s 2015 financial outlook is unchanged. The Company expects to generate organic revenue growth of approximately one percent, and expects to increase its non-GAAP operating margin by more than 100 basis points compared to 2014. Non-GAAP EPS is expected to be flat in 2015, compared to 2014.

For earnings history and earnings-related data on Bruker (BRKR) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Bruker Receives Order for High-Field NMR Systems for Major Upgrade of Magnetic Resonance Research Infrastructure at UC Berkeley
• CMS targets 15% Medicare lab fee cuts, putting DGX and LH revenue at risk